Related Experiment Video
Updated: Jun 25, 2026

Real-Time cAMP Dynamics in Live Cells Using the Fluorescent cAMP Difference Detector In Situ
Published on: March 22, 2024
TRAIL inhibited the cyclic AMP responsible element mediated gene expression
Yasuhito Tokumoto1, Katsuhisa Horimoto, Jun Miyake
1Department of Bioengineering, The University of Tokyo, Bunkyo-ku, Japan. y.tokumoto@will.dpc.u-tokyo.ac.jp
Abstract:
Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) not only causes apoptotic cell death in tumor cells, but also activates some transcription factors and affects several other cellular functions. In this study, we observed the effect of administration of TRAIL on gene expression downstream of the cyclic AMP responsive element (CRE) enhancer by using the signal transduction reporter cis-element plasmid pCRE-d2EGFP. Western blotting showed that after administration of TRAIL, the expression level of reporter protein d2EGFP was down-regulated in NIH3T3 cells. To confirm the TRAIL-induced down-regulation of CRE enhancer controlled gene expression, DNA Chip time series analysis of the intrinsic genes expressed in NIH3T3 cells was carried out. As a result, the expression levels of six genes, which have CRE sequence in their promoter region, were slightly down-regulated within three hours after administration of TRAIL.
Insights
Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) down-regulates gene expression controlled by the cyclic AMP responsive element (CRE) enhancer. This finding was observed in NIH3T3 cells using reporter assays and gene expression analysis.
Area of Science:
- Cellular biology
- Molecular biology
- Biochemistry
Background:
- Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) is known to induce apoptosis in tumor cells.
- TRAIL also influences other cellular functions, including transcription factor activation.
- The precise impact of TRAIL on specific gene regulatory pathways remains an area of investigation.
Purpose of the Study:
- To investigate the effect of TRAIL administration on gene expression regulated by the cyclic AMP responsive element (CRE) enhancer.
- To determine if TRAIL influences the activity of signaling pathways involving CRE.
Main Methods:
- Utilized the signal transduction reporter cis-element plasmid pCRE-d2EGFP to monitor CRE-driven gene expression.
- Employed Western blotting to quantify the expression levels of the reporter protein d2EGFP.
- Performed DNA Chip (gene expression) time series analysis to assess changes in endogenous gene expression.
Main Results:
- Administration of TRAIL led to down-regulation of the d2EGFP reporter protein in NIH3T3 cells.
- DNA Chip analysis confirmed TRAIL-induced down-regulation of gene expression controlled by the CRE enhancer.
- Expression levels of six genes containing a CRE sequence in their promoter region were slightly decreased within three hours of TRAIL administration.
Conclusions:
- TRAIL negatively regulates gene expression downstream of the CRE enhancer.
- TRAIL affects cellular functions through modulation of CRE-mediated transcription.
- These findings reveal a novel mechanism of TRAIL action on gene expression regulation.
More Related Videos
Related Concept Videos
Intracellular Signaling Cascades
cAMP-dependent Protein Kinase Pathways
Cell Specific Gene Expression
Global Regulatory Systems
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
GPCRs Regulate Adenylyl Cylase Activity
Two...

